NLRP3 and fatty liver disease: Furthermore, the excessive ROS production can activate NLRP3-mediated inflammation, strengthening the generation of inflammatory cytokines and ultimately promoting the progression of simple fatty liver to NASH (Machado and Diehl, 2016; Lee J. et al., 2019; Lee Y. et al., 2019).